Circulating microRNAs in Small Testicular Masses and Retroperitoneal Post-chemotherapy Residual Masses.
Recruiting now
Conditions studied: Testicular Cancer
In brief
The purpose of this study is to evaluate the diagnostic performance of circulating microRNAs in detecting the presence of germ cell cancer in patients with small testicular mass or retroperitoneal post-chemotherapy residual mass and suitable for testis sparing surgery and retroperitoneal lymph node dissection, respectively.
Key facts
- Study ID
- NCT06620016
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- People needed
- 60
- Starts
- 2024-10-01
- Expected to finish
- 2027-10-31
- Last updated by the study team
- 2024-10-21
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Age >= 18 years
- Single testicular lesion, with < 2 cm diameter and < 30 % testicular volume involvement;
- Negative Serum Tumour Markers;
- Suitable for testis sparing surgery;
- Informed consent.
You may not qualify if…
- None
- COHORT B:
- Inclusion Criteria:
- Age >= 18 years
- Single/multiple post-chemotherapy retroperitoneal lymph node lesion, with > 1 cm (non seminomatous) / > 3 cm (seminomatous) diameter in patients with previous testicular germ cell primary tumour;
- Negative Serum Tumour Markers;
- Suitable for retroperitoneal lymph node dissection;
- Informed consent.
- Exclusion Criteria:
- None
Where it is running
- IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di S. Orsola — Bologna, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.